Thalidomide-O-amido-C4-NH2
Catalog No. A20184
Thalidomide-O-amido-C4-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
| Catalog Num | A20184 |
|---|---|
| M. Wt | 402.4 |
| Formula | C19H22N4O6 |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 1799711-24-2 |
| Synonyms | Cereblon Ligand-Linker Conjugates 6; E3 Ligase Ligand-Linker Conjugates 19 |
| SMILES | NCCCCNC(COC1=C(C(N2C(CCC3=O)C(N3)=O)=O)C(C2=O)=CC=C1)=O |
Thalidomide-O-amido-C4-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 24.85 mL | 124.25 mL | 248.51 mL |
| 0.5 mM | 4.97 mL | 24.85 mL | 49.7 mL |
| 1 mM | 2.49 mL | 12.43 mL | 24.85 mL |
| 5 mM | 0.5 mL | 2.49 mL | 4.97 mL |
*The above data is based on the productmolecular weight 402.4. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.